It sits on almost every comprehensive blood panel. It's one of the few numbers on your labs you can genuinely act on. And most people — including plenty who've had it tested three or four times — have never had it explained properly.
Homocysteine shows up every time you use protein. Understanding the two-step exit it needs is the entire key to reading this marker correctly.
Every time your body strips a methyl group off methionine — an amino acid you get from meat, eggs, and dairy — to power one of hundreds of methylation reactions (DNA repair, neurotransmitter production, detoxification), what's left behind is homocysteine.
Homocysteine isn't reused for anything. It's a dead end with exactly two doors out. Block either one, and it backs up in your bloodstream. That backup is the number on your lab report.
Homocysteine is one of the few numbers on a standard panel that reflects an active, live process — your methylation cycle — rather than a snapshot of damage that's already occurred. Elevated homocysteine is an independent, well-established risk factor for cardiovascular disease, stroke, blood clots, cognitive decline, and pregnancy complications.
The part I actually care about most, though, is what it catches early. Someone's serum B12 can come back "normal" while their cells are functionally starved of it — homocysteine will flag that months, sometimes years, before anything else does. It's an early-warning marker, not a confirmation of damage already done.
Most labs won't flag anything under 15 µmol/L. Functional medicine sets the bar much lower — and that's the number worth actually tracking.
High blood pressure, high uric acid, elevated LDL, inflammation, thyroid antibodies, blood sugar — homocysteine sits in the middle of a genuine feedback network, not a list of unrelated coincidences.
High homocysteine damages the vessel lining directly, then floods the area with reactive oxygen species. That oxidative load flips on NF-κB, the body's master inflammatory switch, which drives up IL-6, TNF-α, and CRP. This is why elevated homocysteine and elevated CRP so often land on the same panel together — that's not coincidence, it's cause and effect.
Of everything on this page, this is the one straightforward cause-and-effect. B12 and folate (as active 5-MTHF) are the literal cofactors needed to convert homocysteine back into methionine. Take either one away, and the recycling line jams immediately.
Uric acid and homocysteine are cleared through the same organ and stressed by the same triggers. Both climb when the kidneys are under strain, and both rise alongside insulin resistance and oxidative stress. High uric acid also directly reduces nitric oxide availability — the same pathway homocysteine damages — so the two rarely move independently of each other.
Homocysteine attacks the endothelium — the thin lining inside blood vessels responsible for producing nitric oxide, the molecule that keeps vessels relaxed and open. Chronically elevated homocysteine cuts nitric oxide output, stiffens arterial walls, and promotes vasoconstriction. Over time, that shows up as blood pressure that doesn't fully explain itself through diet, sodium, or weight alone.
The connection most people miss entirely. An underactive thyroid — rising TSH, especially alongside Hashimoto's with positive Anti-TPO or Anti-Tg antibodies — slows the enzymes homocysteine needs for remethylation, and reduces blood flow to the kidneys. Net effect: homocysteine climbs even when B-vitamin intake is perfect.
Homocysteine oxidizes LDL particles. Oxidized LDL is the version that actually gets swallowed by macrophages and built into arterial plaque — plain LDL mostly just circulates and does very little on its own.
Insulin resistance slows the same methylation enzymes homocysteine depends on for clearance. Once diabetes is established, kidney involvement (diabetic nephropathy) further blocks removal. Blood sugar dysregulation and homocysteine end up reinforcing each other in a loop.
Inflammation, oxidized LDL, high blood pressure, clotting — homocysteine doesn't just sit alongside heart attack risk on a chart. It actively feeds three of the mechanisms that cause one.
A heart attack happens when a coronary artery narrowed by plaque gets suddenly blocked by a blood clot, cutting off oxygen to part of the heart muscle. Homocysteine has a hand in building the plaque, making that plaque unstable, and making the blood more likely to clot on top of it — three separate pushes toward the same event.
Chronic homocysteine exposure injures the vessel lining directly. That injury is what kicks off atherosclerosis — plaque quietly building inside artery walls, often years before any symptom shows up.
As covered above, homocysteine oxidizes LDL into the form that actually gets built into plaque — including the soft, unstable plaque most likely to rupture rather than the calcified kind that stays put.
Homocysteine activates platelet aggregation and several clotting factors. That makes the blood more prone to forming the clot that finally blocks a narrowed artery — the actual event of a heart attack.
Meta-analyses of prospective studies have linked every 5 µmol/L rise in homocysteine to roughly a 20–25% increase in coronary heart disease risk — independent of LDL, blood pressure, and smoking status. Independent is the key word: this risk shows up even after the usual suspects are already accounted for.
Possibly the single biggest driver of elevated homocysteine that isn't a vitamin at all. The kidneys clear a meaningful share of circulating homocysteine — even mild, subclinical impairment in eGFR or creatinine will push it up regardless of diet or supplementation.
Poor converters can't turn folic acid into active 5-MTHF efficiently. They need active methylfolate directly, not more folic acid — supplementing the wrong form can even make things worse.
CBS runs the B6-dependent exit door (transsulfuration). MTR and MTRR support the B12-dependent recycling enzyme. Variants in any of these change how much of each cofactor a person actually needs.
All three independently raise homocysteine by depleting B-vitamins and increasing oxidative load — worth flagging before assuming a genetic or clinical cause.
The BHMT pathway is a second remethylation route that doesn't need B12 or folate at all. Low choline intake removes this backup entirely — worth checking before assuming it's purely a B-vitamin issue.
Ask for fasting plasma homocysteine alongside B12, folate, B6, TSH, Anti-TPO, and Anti-Tg — testing it alone tells you the number moved, not why.
Under 7–8 µmol/L, not under 15. "Within range" on a standard lab does not mean optimal here.
Vitamin status, thyroid function, kidney clearance, and MTHFR genetics all move this number differently — fix the one that's actually broken.